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Vascular endothelial growth factor (VEGF)-dependent angiogenesis plays a crucial role in the corpus 
leteum formation and their functional maintenances in mammalian ovaries. We recently reported that 
the activation of hypoxia-inducible factor (HIF)-1α signaling contributes to the regulation of VEGF 
expression in the luteal cells (LCs) in response to hypoxia and human chorionic gonadotropin (HCG). 
This study was designed to test the hypothesis that, HIF prolyl-dydoxylases (PHDs) express in LCs and 
overexpression of PHD attenuates the expression of VEGF induced by HCG in LCs. By real-time PCR 
and western blot analysis, we examined the expression of PHDs, confirmed the plasmid transfection 
and their expression and also investigated the changes of HIF-1α and VEGF expression after treatment 
with HCG and PHD2 transgenes. PHD2 expression was significantly higher than the others, indicating 
its main roles. Moreover, a significant increase of VEGF mRNA was found after HCG treatment, while 
this increased VEGF mRNA was also blocked by PHD2 overexpression in LCs. Further analysis also 
found that, this HCG-induced increase of VEGF mRNA was consistent with the level of HIF-1α protein, 
which is regulated by HIF prolyl-dydoxylase -mediated degradation. Taken together, our results 
indicated that, PHD2 mainly expressed in LCs and HCG-induced VEGF expression can be blocked by 
PHD2 overexpression through HIF-1α -mediated mechanism in LCs. This PHD2-mediated transcriptional 
activation may be one of the important mechanisms regulating VEGF expression in LCs during 
mammalian corpus leteum development.  
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Vascular endothelial growth factor (VEGF) plays a 
fundamental role in the physiological angiogenesis and 
the vascularization of the follicular luteinizing granulosa 
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and Stouffer, 1997; Kaczmarek et al., 2005; Shimizu et 
al., 2007a; Shimizu and Miyamoto, 2007b). Because 
inhibition of VEGF in vivo during the luteal phase will 
prevent luteal angiogenesis and subsequent proges-
terone secretion (Duncan et al., 2008; Fraser et al., 2005; 
Fraser et al., 2006; Wulff et al., 2001), the excess VEGF 
generation during the vascularization of multiple follicles 
is also thought to cause ovarian hyperstimulation 
syndrome (OHSS) (Nastri et al., 2010; Neulen et al., 
1995; Zhang et al., 2010a). Therefore, the molecular 
regulation of luteal VEGF expression becomes more and 
more important. 
We recently  reported  that,  HIF-1α  contributes  to  the 




transcriptional regulation of VEGF in LCs (Zhang et al., 
2010b). HIF-1, a helix-loop-helix transcriptional factor, 
which consists of HIF-1α and HIF-1β, has been cloned 
and characterized as a transcriptional activator of many 
oxygen-sensitive genes, such as erythropoietin, heme 
oxygenases, transferrin and several glycolytic enzymes 
(Wang et al., 1995; Wang and Semenza, 1993a, b, 1995; 
Wenger et al., 1996). It has been indicated that, HIF-1α is 
an inducible protein by a decrease in tissue or cellular O2. 
HIF-1β is not inducible, but it can be bound to HIF-1α to 
form a dimer to activate the transcription of many genes 
containing cis hypoxia-response element (HRE) in their 
promoter or enhancer regions. Previous chromatin immu-
noprecipitation (ChIP) results have already indicated that, 
estrogen can simultaneously induce the recruitment of 
both HIF-1 (α and β) to the upstream HRE and ERα to 
the proximal GC-rich region of the VEGF promoter, which 
mediates transcriptional activation of the mouse VEGF 
gene (Kazi et al., 2005; Kazi and Koos, 2007; Molitoris et 
al., 2009). 
It has been demonstrated that, HIF prolyl-hydroxylases 
are the major enzymes to promote the degradation of 
hypoxia inducible factor (HIF)-1α (Bruick and McKnight, 
2001; Ivan et al., 2001; Jaakkola et al., 2001). HIF prolyl-
hydroxylases catalyze site-specific proline hydroxylation 
of HIF-1α and prolyl-hydroxylated HIF-1α is recognized 
and targeted for degradation by the ubiquitin-proteasome 
pathway. Three isoforms of HIF prolyl-hydroxylase, 
including prolyl hydroxylase domain-containing proteins 
1, 2 and 3 (PHD1, 2 and 3), have been identified (Bruick 
et al., 2001; Epstein et al., 2001; Ivan et al., 2001; 
Jaakkola et al., 2001). This study indicated that, PHD2 is 
most abundantly expressed in LCs. Our previous studies 
have also indicated that, PHD2 participates in the 
functional regulation through regulating HIF-1α level 
(Wang et al., 2010) and the importance of PHD2 in 
angiogenesis (Chan and Giaccia, 2010). 
Given the important role of PHD2 in the regulation of 
HIF-1α levels, we hypothesize that, PHD2 signaling 
pathway exists in ovarian angiogenesis and over-
expression of PHD2 attenuates the expression of VEGF 
induced by HCG in LCs. We examined the effect of HCG 
on the expression of HIF-1α and determined the role of 
PHD2 and the primary isoform of PHDs, in HCG-induced 
activation of HIF-1α by transfection of PHD2 transgenes 
into LCs. We also revealed the changes of VEGF mRNA 
level in each group. Our result demonstrated that, PHD2 
was the mediator of cellular HIF-1α and its target gene 
VEGF in LCs, which may be an important mechanisms 
regulating VEGF-dependent angiogenesis during mam-
malian corpus leteum development. 
 
 









Center, Fuzhou, China) were used in this study. All animals were 
maintained under a 12 h light/12 h dark schedule with food and 
water available ad libitum. The study was conducted in accordance 
with guidelines of the Institutional Animal Care and Use Committee 
and was approved by the Ethics Committee on Animal 
Experimentation of the University. All efforts were made to minimize 
animal discomfort and to reduce the number of animals used. 
 
 
Isolation and culture of rat LCs 
 
Rat LCs were isolated and cultured as methods described 
previously (Conti et al., 1977; Pepperell et al., 2003; Thomas et al., 
1978). Briefly, the rats received a subcutaneous injection of equine 
chorionic gonadotropin (eCG; Sigma-Aldrich, St. Louis, MO, US; 50 
international units (IU)) and an ovulatory dose (25 IU) of human 
chorionic gonadotropin (HCG; Sigma) 64 h later. Ovaries was 
obtained at 5 days after HCG injection and minced with a razor 
blade. Tissue was digested in medium 199 (GIBCO, Grand Island, 
NY, US; which contains Earle's salts but no L-glutamine and no 
sodium bicarbonate.) containing 1% fetal calf serum (FCS; GICBO) 
and 2,000 IU collagenase (GIBCO) plus 3,000 IU of DNase (Sigma) 
per gram of tissue for 1 h at 37°C under 95% air with 5% CO2. The 
contents of the flask were filtered through nylon mesh (BD, Franklin 
Lakes, NJ, US) and centrifuged (100 g, 5 min); the supernatant 
fraction was discarded and the pellet was washed three times with 
fresh medium. The final cell concentration was 10
6
 cells per ml and 
cell incubation was carried out in 6-well culture plates. Cell numbers 
were determined with a hemocytometer and cell viability was >90% 
as assessed by exclusion of Trypan blue dye. 
 
 
Transfection of plasmids expressing rat PHD2 into the cells 
 
Plasmids encoding rat full-length PHD2 cDNA are generous gifts 
from Dr. Ningjun Li (Virginia Commonwealth University). The 
expression and function of rat PHD2 protein by the plasmids has 
been validated by previous studies (Huang et al., 2002; Li et al., 
2007; Percy et al., 2006; Wang et al., 2010). Plasmids transfections 
were performed using lipids (DOTAP/DOPE, Avanti Polar Lipids, 
Inc.) according to the manufacturer’s instructions. In brief, 5 µg of 
DNA was mixed with lipids solution at a ratio of 1:10 (DNA:lipid, 
w/w) in serum free culture medium (5 ml for a 10 cm dish). Cells 
were incubated with this transfection medium for 5 h and switched 




Cell treatment and experimental groups  
 
After plasmid transfection, the cells were switched to serum-free 
medium containing 100 µM of HCG. After HCG treatment for 18 h, 




RNA extraction and quantitative RT-PCR analysis of the mRNA 
levels of PHD1, 2 and 3, HIF- 1α and VEGF 
 
Total RNA was extracted using TRIzol solution (Life Technologies, 
Inc. Rockville MD, US) and then reverse-transcribed (RT) (cDNA 
synthesis kit, Bio-Rad, Hercules, CA, US). The RT products were 
amplified using  SYBR  green for  PHD1 (forward primer 5'-GCT 
GCT GCG TTG GTT AC-3' and reverse primer 5'-GCC TCC TGG 
TTC TCT TG-3'; GenBank accession no.: NM001004083), PHD2 
(forward primer 5'-CTG GGA CGC CAA GGT GA-3' and reverse 
primer 5'- CAA TGT CAG CAA ACT GG-3'; GenBank accession 
no.:   NM178334),   PHD3   (forward  primer 5'-GTT CAG CCC TCC  






Figure 1. PHD2 mRNA expression in LCs. The relative mRNA levels of PHDs by Real-time 
PCR analysis. Each value represents the mean ± SE. One-way analysis of variance 
(ANOVA) was used to analyze the data. Different superscripts denote significant values 




TAT GC-3' and reverse primer 5'-ACC ACC GTC AGT CTT TA-3'; 
GenBank accession no.: NM019371), HIF-1α(forward primer 5'-
CTG GCA CGG GGA TGA TAC AGC-3' and reverse primer 5'-TCT 
CAT CCA TTG ACT GCC CCA G-3'; GenBank accession no.: 
AF057308) and VEGF (forward primer 5'-ACG AAG CGC AAG AAA 
TCC C-3' and reverse primer 5'-TTA ACT CAA GCT GCC TCG CC-
3'; GenBank accession no.: M32167 ) with an iCycler iQ real time 
PCR detection system (Bio-Rad). The level of 18 rRNA (forward 
primer 5'-CGC CGC TAG AGG TGA AAT TC-3' and reverse primer 
5'-TCT TGG CAA ATG CTT TCG C-3'; GenBank accession no.: 
M11188) was used as an endogenous control. The relative gene 
expressions were calculated in accordance
 
with the ∆∆Ct method. 





Preparation of nuclear extracts and cytosolic protein and 
western blot analyses for protein levels of HIF-1α and PHD2 
 
Nuclear protein was prepared as we described previously (Li et al., 
2007; Wang et al., 2010; Zhang et al., 2010b). Cytosolic protein and 
nuclear protein were separately collected. The cytosolic protein was 
used for western blot analyses of PHD2. The nuclear fraction was 
used for western blot analyses of HIF-1α. Primary antibodies used 
in this study included HIF-1α (monoclonal, Novus Biologicals, 1:300 
dilution) and PHD2 (rabbit polyclonal, Novus Biologicals, 1:300). 
 
 
Determination of HIF-4-prolyl hydroxylase activity 
 
HIF-1α-peptide-specific conversion of 2-oxoglutarate into succinate 
provides a hydroxyl group for HIF-1α to be prolyl hydroxylated. This 
reaction has been widely used for the determination of PHD activity 
by measuring HIF-1α-dependent conversion rate of 2-oxoglutarate 






Data are presented as mean ± SE. The significance
 
of differences 
in mean values within and between multiple groups
 
was evaluated 
using an ANOVA followed by a Duncan’s multiple
 
range tests. 
Student’s t-test was used to evaluate statistical
 
significance of 








PHDs mRNA expression in LCs 
 
This study showed that, PHD2 mRNA level was almost 
three times higher than PHD1 mRNA level, while PHD3 
was just half of PHD2 mRNA level, indicating that all of 
the three PHDs were expressed and PHD2 is most 
abundantly expressed in LCs (Figure 1). 
 
 
Effects of HCG and PHD2 transgene on PHD2 mRNA 
level in LCs 
 
HCG treatment increased PHD2 mRNA level significantly 
than the control group in LCs (Figure 2), while PHD2 
mRNA level also increased dramatically in PHD2 
transgene group after HCG treatment than those in the 
control group and HCG-treated group (Figure 2), 
indicating high transfection efficiency and high expression 
level of PHD2 plasmid. 
 
 
Effects of HCG and PHD2 transgene on PHD2 protein 
level and PHD2 activity in LCs 
 
To further confirm the role of PHD2 in PHD2-transfected 
LCs, we also performed the experiments to detect PHD2 
protein level and PHD2 biological activity in each group 
(Figures 3 and 4). Our results showed that, HCG 
increased PHD2 protein level in some degree  (Figure 3),  






Figure 2. Effects of HCG and PHD2 plasmid on PHD2 mRNA level in LCs. The 
relative mRNA levels of PHD2 by real-time RT-PCR analysis. Each value 
represents the mean ± SE. One-way analysis of variance (ANOVA) was used to 
analyze the data. Different superscripts denote significant values between the other 






Figure 3. Effects of HCG and PHD2 plasmid on PHD2 protein level in LCs. Panel A: 
Representative ECL gel documents of western blot analyses depicting the protein 
level of PHD2; panel B: summarized intensities of PHD2 blot normalized to control. 
Each value represents the mean ± SE. One-way analysis of variance (ANOVA) was 
used to analyze the data. Different superscripts denote significant values between the 
other groups (P < 0.05) by Duncan’s multiple range test. n = 6 batches of cells. 






Figure 4. Effects of HCG and PHD2 plasmid on PHD2 activity in LCs. HIF-4-prolyl 
hydroxylase activity in each group by (
14
C)-2-OG conversation rate. Each value represents 
the mean ± SE. One-way analysis of variance (ANOVA) was used to analyze the data. 
Different superscripts denote significant values between the other groups (P < 0.05) by 




but a significant increase of PHD2 protein level was 
found in LCs transfected with PHD2 plasmids (Figure 3). 
The results of PHD activity had also demonstrated that 
these proteins have biological activity in PHD2-
transfected LCs (Figure 4). 
 
 
 Effects of HCG and PHD2 transgene on VEGF and 
HIF-1α mRNA level in LCs 
 
In this study, HCG significantly increased VEGF and HIF-
1α mRNA expression in LCs. To better understanding of 
the important role of PHD2 in the LCs, we also examined 
the level of VEGF and HIF-1α mRNA in LCs transfected 
with PHD2 plasmid (Figure 5). Interestingly, a dramatic 
decrease of VEGF was found in PHD2-transfected LCs 
(Figure 5b), while HIF-1α mRNA had no obvious changes 
compare with HCG-treated LCs (Figure 5a). 
 
 
Effects of HCG and PHD2 transgene on HIF-1α 
protein level in LCs 
 
It has been demonstrated that, HIF prolyl-dydroxylases 
are major enzymes to promote the degradation of HIF-1α 
(Bruick et al., 2001; Epstein et al., 2001; Ivan et al., 2001; 
Jaakkola et al., 2001); therefore, we also examined the 
HIF-1α protein levels in each group (Figure 6). A signif-
icant decrease of HIF-1α protein was found in PHD2-
transfected LCs, which was consistent with our previous 
reports (Li et al., 2007; Wang et al., 2010), indicating that, 
PHD2 may regulate VEGF expression via HIF-1α 
pathway in LCs during corpus leteum development. 
DISCUSSION 
 
The results of our present study clearly demonstrated 
that HCG induced VEGF and HIF-1α expression in LCs, 
which was blocked by overexpression of PHD2, 
suggesting PHD2-mediated VEGF expression via HIF-1α 
pathway could be an important mechanism of VEGF-
dependent angiogenesis during mammalian corpus 
luteum development. 
The corpus luteum (CL) is a temporary endocrine 
structure in mammals, which plays an important role in 
the female reproductive cycle and is formed temporarily 
from a ruptured and ovulated follicle with rapid angio-
genesis (Fraser et al., 2005; Nishimura and Okuda, 2010; 
Wulff et al., 2001; Young et al., 2000; Zhang et al., 
2010a). Vascular endothelial growth factor (VEGF) is 
thought to play a paramount role in the regulation of 
normal and abnormal angiogenesis in the ovary (Fraser 
et al., 2005; Kaczmarek et al., 2005; Lee et al., 1997; 
Neulen et al., 1995; Shimizu et al., 2007a, b; van den 
Driesche et al., 2008; Zhang et al., 2010a), especially in 
the newly formed CL. Our previous experiments have 
already provided the direct evidences that VEGF is 
transcriptionally activated by HIF-1-mediated mechanism 
in LCs under hypoxia (Zhang et al., 2010b), which is 
caused by ovulation of the ruptured follicle with bleeding 
and an immature vasculature (Kaczmarek et al., 2005; 
Nishimura and Okuda, 2010). However, many reports 
have also shown that, reproductive hormones like HCG 
also take part in the primary regulation of VEGF 
expression in the ovary. For example, VEGF mRNA 
expression in human luteinized granulosa cells has been 
shown to be  dose  and  time  dependently  enhanced  by  











Figure 5. Effects of HCG and PHD2 plasmid on HIF-1α and VEGF mRNA 
level in LCs.  Panel A: the relative mRNA levels of HIF-1α by real-time 
PCR analysis. Panel B: the relative mRNA levels of VEGF by real-time 
PCR analysis. Each value represents the mean ± SE. One-way analysis of 
variance (ANOVA) was used to analyze the data. Different superscripts 
denote significant values between the other group (P < 0.05) by Duncan’s 




HCG in vitro (Nastri et al., 2010; Neulen et al., 1995). 
Chronic or acute  expo-sure to HCG directly stimulates 
VEGF production and secretion by monkey (Christenson 
and Stouffer, 1997) and human luteinized granulosa cells 
(Lee et al., 1997; Nastri et al., 2010; Neulen et al., 1995; 
Wulff et al., 2001). And the administration of a GnRH 
antagonist decreased VEGF mRNA expression in the 
monkey corpus luteum (Ravindranath et al., 1992). In 
addition, luteal vascularization and the development of 
OHSS are absolutely dependent on LH/HCG stimulation 
(Nastri et al., 2010; Neulen et al., 1995). Furthermore, in 
a fully formed highly vascular, corpus luteum HCG also 
up-regulates VEGF expression (Wulff et al., 2001). 
Therefore, this study examined the induced effect of HCG 
on VEGF mRNA expression in LCs. Interestingly; we 
found that VEGF expression is induced by HCG in LCs 
and HCG-stimulated HIF-1α protein expression is highly 
correlated with VEGF expression, indicating HCG 
stimulated VEGF expression via HIF-1α signaling pathway.  
Many studies have already indicated that, HIF-1α 
regulates the expression of many genes whose protein 
products play critical roles in the developmental and 
physiological processes including angiogenesis, erythro-
poiesis, glycolysis, iron transport and cell proliferation/ 
survival (Miyazawa et al., 2009, 2010; Nishimura et al., 
2010; Wulff et al., 2001; Yaba et al., 2008; Zhong et al., 
2000). Because HIF-1α activates the transcription of 
VEGF, which is required for angiogenesis, it is possible 
that, HCG may mediate angiogenesis via HIF-1α/VEGF 
pathway. In addition to a detailed exploration of the 
downstream mechanism of HIF-1α, studies have clarified 
the upstream process modulated by PHDs, which regulates 






Figure 6. Effects of HCG and PHD2 plasmid on HIF-1α protein level in LCs. 
Panel A: representative ECL gel documents of western blot analyses depicting 
the protein level of HIF-1α; panel B: summarized intensities of HIF-1α blot 
normalized to control. Each value represents the mean ± SE. One-way 
analysis of variance (ANOVA) was used to analyze the data. Different 
superscripts denote significant values between the other groups (P < 0.05) by 




HIF-1α degradation by the ubiquitin-protea-some 
pathway. In particular, PHD2 has been drawing 
considerable attention because PHD2 is considered to be 
the key oxygen sensor of all identified PHD enzymes 
(Chan et al., 2010; Wang et al., 2010), as knockdown of 
PHD2 results in elevated HIF protein and several recent 
studies have highlighted the importance of PHD2 in 
tumourigenesis (Chan et al., 2010). This study found that, 
HCG induced the activation of HIF-1α and over-
expression of PHD2 transgenes blocked this activation of 
HIF-1α and its target gene VEGF, after HCG treatment. 
These results indicate that, PHD2 is involved in HIF-1α-
mediated gene activations in LCs treated by HCG, which 
may reveal a novel mechanism about VEGF-dependent 
angiogenesis during mammalian corpus luteum develop-
ment. 
In summary, this study clearly demonstrates that HCG 
induces HIF-1α and VEGF expression in LCs and is also 
the first time to provide direct evidences indicating PHDs 
exists in rat LCs and HCG-induced VEGF expression can 
be blocked by overexpression of PHD2 transgenes. This 
PHD2-mediated VEGF expression may be one of the 
important mechanisms about VEGF-dependent angio-
genesis during the corpus leteum formation in the 
mammalian ovary. Furthermore, PHD2 antagonism 
affords an opportunity for the development of novel 
treatments for fertility control and for some types of 
ovarian dysfunction (Chan and Giaccia, 2010; Miyazawa 
et al., 2009, 2010), particularly those conditions characte-
rized by pathological angiogenesis and excessive 
vascular permeability, such as polycystic ovarian 
syndrome (PCOS), ovarian hyperstimulation syndrome 
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